News AlzeCure Pharma AB

Equities

ALZCUR

SE0010133785

Market Closed - Nasdaq Stockholm Other stock markets 11:18:17 2024-05-03 am EDT			5-day change	1st Jan Change
1.75 ^SEK	-2.78%		-13.37%	-43.73%

Apr. 25	AlzeCure Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 10	Jan Lundberg acquired an unknown minority stake in AlzeCure Pharma AB (OM : ALZCUR).	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AlzeCure Pharma publishes prospectus	Apr. 29	AQ
AlzeCure publishes its interim report for January – March 2024	Apr. 25	AQ
AlzeCure Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg invests in AlzeCure and is proposed for election to its board	Apr. 10	AQ
Jan Lundberg acquired an unknown minority stake in AlzeCure Pharma AB (OM : ALZCUR).	Apr. 09	CI
AlzeCure Pharma publishes its Annual Report for 2023	Apr. 04	AQ
AlzeCure presents new data regarding the TrkA-NAM pain project at IASP 2024	Apr. 03	AQ
AlzeCure Pharma AB Presents New Data Regarding the TrkA-NAM Pain Project at IASP 2024	Apr. 03	CI
AlzeCure to partake in Redeye Theme, Alzheimer on March 21	Mar. 15	AQ
AlzeCure to partake in Redeye Theme: Alzheimer on March 21	Mar. 14	AQ
AlzeCure Presents New Preclinical Data with NeuroRestore ACD856 at Leading Alzheimer's Conference	Mar. 07	CI
AlzeCure presents new preclinical data with NeuroRestore ACD856 at leading Alzheimer's conference	Mar. 07	AQ
AlzeCure Pharma AB Publishes Clinical Results Supporting Continued Development of NeuroRestore ACD856 Against Alzheimer's	Mar. 05	CI
AlzeCure publishes clinical results supporting continued development of NeuroRestore ACD856 against Alzheimer's	Mar. 05	AQ
AlzeCure's Alzheimer's project NeuroRestore ACD856 is granted an additional patent	Feb. 29	AQ
AlzeCure publishes its Year-end report for January – December 2023	Feb. 27	AQ
AlzeCure Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 27	CI
AlzeCure Pharma broadcasts live expert event on Alzheimer's around highly current gamma-secretase modulators	Feb. 12	AQ
AlzeCure Pharma AB Announces Live Expert Event on Alzheimer's Around Highly Current Gamma-Secretase Modulators	Feb. 12	CI
AlzeCure gets Late Breaking abstract of new preclinical data with ACD856 accepted at AD/PD 2024 conference	Feb. 06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AlzeCure Pharma AB

Equities

ALZCUR

SE0010133785

Summary

Filters